TipRanks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market
TXMD
TherapeuticsMD
RESEARCH TOOLSreports
Want to see TXMD full AI Analyst Report?

TherapeuticsMD (TXMD) Income Statement

2,247 Followers

TherapeuticsMD Income Statement

Last quarter (Q2 2026), TherapeuticsMD's total revenue was $869.00K, a decrease of -8.72% from the same quarter last year. In Q2, TherapeuticsMD's net income was $155.00K. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 3.02M$ 1.76M$ 1.30M$ 69.96M$ 2.57M
Gross Profit
$ 3.02M$ 1.76M$ 1.30M$ 68.57M$ 1.17M
Operating Expenses
$ 7.24M$ 6.61M$ 9.82M$ 57.90M$ 80.75M
Depreciation and Amortization
$ 1.19M$ 1.28M$ 922.00K$ 1.20M$ 736.00K
EBITDA
$ -3.02M$ -3.56M$ -7.60M$ 11.86M$ -78.84M
Operating Income
$ -4.21M$ -4.84M$ -8.52M$ 10.66M$ -79.58M
Other Income/Expenses
$ 3.56M$ 2.50M$ 781.00K$ -9.59M$ 272.00K
Pretax Income
$ -653.00K$ -2.34M$ -7.74M$ 1.07M$ -79.31M
Net Income
$ -569.00K$ -2.18M$ -10.28M$ 112.00M$ -172.41M
Per Share Metrics
Basic EPS
$ -0.05$ -0.19$ -0.55$ 12.41$ -25.83
Diluted EPS
$ -0.05$ -0.19$ -0.74$ 12.41$ -25.83
Weighted Average Shares Outstanding
 11.57M 11.53M 10.44M 9.03M 7.96M
Weighted Average Shares Outstanding (Diluted)
 11.57M 11.53M 10.44M 9.03M 7.96M
Currency in USD

TherapeuticsMD Earnings and Revenue History